The AI for healthcare industry in the DACH region is at the forefront of transforming patient care and medical advancements. Companies range from startups to established pharma, focusing on AI applications in diagnostics, treatment, and data management. They offer solutions that streamline processes, improve diagnostics, and enhance patient outcomes. This rapidly growing sector is increasingly driven by innovations in machine learning and data analytics, promising significant shifts in how healthcare is delivered. The integration of AI not only aims to reduce costs but also aspires to personalize medicine, ensuring that treatments are more effective and targeted.


The list of investors in the AI for healthcare space features a mix of corporate and venture capital firms, primarily based in Switzerland, Germany, and Austria. With founding years stretching from 1979 to 2014, these firms vary in size, from small teams to large organizations. In 2024, their investment counts reflect a robust engagement in health tech, with notable players like Novartis and Speedinvest participating in multiple funding rounds. This investment activity underscores a proactive approach to championing healthcare innovation.


Top 13 AI for Healthcare Investors in DACH


1. Novartis

  • Website: novartis.com
  • Type: Corporate
  • Headquarters: Basel, Basel, Switzerland
  • Founded year: 1996
  • Headcount: 10001+
  • Number of deals in 2024: 7
  • LinkedIn: novartis

Novartis AG is a leading pharmaceutical company based in Basel, Switzerland, founded in 1996. The company is dedicated to developing and manufacturing innovative medicines that address serious diseases across various therapeutic areas. Novartis emphasizes research and development to enhance patient outcomes globally. In recent years, Novartis has actively invested in the AI for healthcare sector, participating in notable transactions such as a Series B financing round for Deciphex, which focuses on revolutionizing clinical and non-clinical pathology through AI. They also invested in Patientory, a company that raised $1.5 million in a seed round aimed at improving healthcare data management. Furthermore, Novartis was involved in the Series C funding for Cleerly, which is focused on expanding its healthcare solutions. These investments highlight Novartis's commitment to integrating AI technologies into healthcare, reinforcing their role as a forward-thinking investor in this space.


2. Novartis Venture Fund

  • Website: nvfund.com
  • Type: Venture Capital
  • Headquarters: Basel, Basel, Switzerland
  • Founded year: 1996
  • Headcount: 11-50
  • Number of deals in 2024: 10

The Novartis Venture Fund is a venture capital firm based in Basel, Switzerland, specializing in life sciences investments. Founded in 1996, the fund focuses on providing funding and support to innovative biotechnology and biopharmaceutical companies, helping them develop novel therapeutics and address unmet patient needs. Notably, the fund has participated in several transactions that highlight its engagement with technology-driven healthcare solutions. For instance, it was involved in the Series C funding of Flywheel.io, which raised $27 million to enhance data management in medical imaging, a critical area where AI is applied. Additionally, the fund has supported companies like ImaginAb, which is developing imaging agents for cancer detection, showcasing its interest in technologies that can improve diagnostic capabilities. These investments reflect the fund's commitment to advancing healthcare through innovative technologies, including AI.


3. Verve Ventures

  • Website: verve.vc
  • Type: Venture Capital
  • Headquarters: Zurich, Zurich, Switzerland
  • Founded year: 2010
  • Headcount: 11-50
  • Number of deals in 2024: 25
  • LinkedIn: investiere-venture-capital

Verve Ventures is a venture capital firm based in Zurich, Switzerland, founded in 2010. The firm specializes in deep tech investments across Europe, providing funding and strategic support to science and technology startups. Their investment focus spans various sectors, including climate tech, industrial technology, and health & bio. Notably, Verve Ventures has participated in significant transactions within the healthcare space, such as their involvement in Therapixel, which raised €15M in Series B funding for its medical imaging software, and Retinai, which has successfully raised over $7.7 million in Series B funding in 2024, following earlier rounds of investment. These transactions highlight Verve Ventures' commitment to supporting innovative healthcare solutions, particularly those leveraging AI technologies.


4. Sictic

  • Website: sictic.ch
  • Type: Venture Capital
  • Headquarters: Zurich, Zurich, Switzerland
  • Founded year: 2014
  • Headcount: 201-500
  • Number of deals in 2024: 77
  • LinkedIn: sictic

SICTIC is a not-for-profit organization based in Zurich, Switzerland, that connects smart money investors with innovative Swiss early-stage technology startups. Founded in 2014, SICTIC provides investment opportunities, networking events, and educational resources to facilitate the growth of startups and the investment community. Notably, SICTIC has been involved in several relevant transactions in the healthcare sector, including a seed round for PeriVision, a University of Bern spin-off focused on healthcare technology, which raised between CHF 0.5 and 1 Million to accelerate research and development. Additionally, SICTIC participated in the seed funding for Komed Health, which raised over $1 million to develop a communication platform for healthcare providers. These transactions highlight SICTIC's active role in supporting healthcare innovation through technology investments.


5. HBM Healthcare Investments AG


HBM Healthcare Investments AG is a venture capital firm based in Zug, Switzerland, founded in 2001. The firm specializes in the healthcare sector, managing a diversified portfolio that includes investments in human medicine, biotechnology, medical technology, and diagnostics. In recent years, HBM has been involved in several notable transactions that highlight its commitment to advancing healthcare through innovative technologies. For instance, they participated in Valo Health's Series B and C funding rounds, where Valo Health is known for its AI-driven approaches to drug discovery. Additionally, HBM invested in Freenome's Series D round, a company that employs AI for early cancer detection through blood tests. These investments reflect HBM's strategy to support companies that are at the forefront of integrating AI into healthcare solutions, making them a significant player in the AI for healthcare investment landscape.


6. Speedinvest

  • Website: speedinvest.com
  • Type: Venture Capital
  • Headquarters: Vienna, Vienna, Austria
  • Founded year: 2011
  • Headcount: 51-200
  • Number of deals in 2024: 45
  • LinkedIn: speedinvest

Speedinvest is a venture capital firm based in Vienna, Austria, founded in 2011. The firm specializes in funding early-stage tech startups across Europe, providing both capital and hands-on support to help these startups scale their operations. Speedinvest's investment focus spans various technology sectors, including Deep Tech, Fintech, and SaaS. Notably, they have made significant investments in the healthcare technology sector, participating in funding rounds for companies such as IOMED, a medtech startup that raised €2 million to expand its operations, and Medicus AI, which raised $682,571 in an angel round. Additionally, they have invested in ThinkSono, a company that raised over $2.5 million in a seed round, further demonstrating their commitment to supporting innovative healthcare solutions that leverage AI technologies. Speedinvest leverages a vast network of industry experts to assist their portfolio companies, enhancing their potential for success in the competitive healthcare market.


7. Bayern Kapital

  • Website: bayernkapital.de
  • Type: Venture Capital
  • Headquarters: Landshut, Bavaria, Germany
  • Founded year: 1995
  • Headcount: 11-50
  • Number of deals in 2024: 27
  • LinkedIn: bayern-kapital-gmbh

Bayern Kapital is a venture capital firm based in Landshut, Bavaria, Germany, founded in 1995. The firm specializes in providing investment and growth capital to innovative high-tech startups and scale-ups in Bavaria. They support their clients with financial resources and access to a network of industry experts, helping them navigate the challenges of growth and development in sectors such as life sciences and software. In recent years, Bayern Kapital has been involved in several notable transactions in the healthtech space, including RYVER.AI, which aims to enhance radiology diagnostics using generative AI, and Ebenbuild, which is developing a lung simulation prototype for medical device approval. Their participation in these funding rounds highlights their active role in supporting AI-driven healthcare innovations.


8. Calm/Storm

  • Website: calmstorm.vc
  • Type: Venture Capital
  • Headquarters: Vienna, Vienna, Austria
  • Founded year: 2020
  • Headcount: 1-10
  • Number of deals in 2024: 13
  • LinkedIn: calm-storm

Calm/Storm Ventures is a venture capital firm based in Vienna, Austria, founded in 2020. The firm specializes in early-stage investments in health tech startups, emphasizing purpose-driven founders. Calm/Storm provides not only capital but also support and networking opportunities to help these companies thrive in the competitive health tech landscape. Their portfolio includes diverse teams addressing sensitive health issues. Notably, Calm/Storm has participated in significant funding rounds for companies like Thymia, which raised funds to expand its AI-driven mental health platform, and ThinkSono, which focuses on AI applications in healthcare diagnostics. These transactions highlight Calm/Storm's commitment to advancing AI technologies in the healthcare sector.


9. b2venture

  • Website: b2venture.vc
  • Type: Venture Capital
  • Headquarters: St. Gallen, St. Gallen, Switzerland
  • Founded year: 2000
  • Headcount: 11-50
  • Number of deals in 2024: 15
  • LinkedIn: btovpartners

b2venture is a venture capital firm based in St. Gallen, Switzerland, specializing in early-stage investments in innovative startups across various sectors. Founded in 2000, the firm has established itself as a key player in the European venture capital landscape, providing financial backing and support to entrepreneurs. They collaborate with a community of angel investors to enhance their investment strategy. Notably, b2venture has been involved in significant transactions within the AI for healthcare space, including a Series A funding round for Retinai, which raised approximately $6.2 million in May 2024, focusing on AI solutions for retinal health. They also participated in funding rounds for Healx, which raised $47 million in Series C in August 2024 and $56 million in Series B in October 2019, both aimed at leveraging AI for drug discovery in rare diseases. These transactions highlight b2venture's commitment to supporting innovative healthcare solutions that utilize artificial intelligence.


10. Wellington Partners


Wellington Partners is a venture capital firm based in Munich, Bavaria, Germany, founded in 1998. The firm specializes in life sciences and invests in early- and growth-stage companies, providing both capital and strategic support to entrepreneurs. Their investment strategy emphasizes helping innovative startups develop breakthrough technologies and achieve market success. Notably, Wellington Partners has been involved in several significant transactions in the AI for healthcare sector, including a €14 million Series A investment in Aignostics, a biotech startup that utilizes AI for diagnostics, and a €4.5 million Seed Round for nyra health, which focuses on enhancing AI technology in healthcare. Additionally, their investment in Sidekick Health, a digital therapeutics company, further illustrates their engagement in the healthcare technology landscape, particularly where AI plays a crucial role.


11. IBB Ventures


IBB Ventures is a venture capital firm based in Berlin, Germany, founded in 1997. The firm specializes in early-stage financing and has invested in over 270 startups, providing not only capital but also expertise and resources to help these businesses thrive. Among their notable transactions, IBB Ventures has been involved in multiple funding rounds for Aignostics, a Berlin-based biotech startup focused on computational pathology and AI. Aignostics raised €14 million in a Series A round in 2022, followed by a Series B round of $34 million in 2024, showcasing IBB Ventures' commitment to supporting AI-driven healthcare innovations. Additionally, IBB Ventures has invested in x-cardiac, a startup that is likely exploring AI applications in cardiac health, further solidifying their involvement in the AI for healthcare sector.


12. Debiopharm


Debiopharm is a biopharmaceutical company based in Lausanne, Switzerland, founded in 1979. The company specializes in the development and manufacturing of innovative therapies for cancer and infectious diseases, focusing on high unmet medical needs. Debiopharm partners with academic and pharmaceutical institutions to bridge the gap between drug discovery and patient access. In recent years, they have made significant investments in AI for healthcare, including a co-lead role in the $6 million seed funding for Altis Labs, which employs AI imaging biomarker technology for clinical trials. They also participated in the pre-seed round for StratifAI, which raised $1.66 million, and invested in Raidium's $16.9 million seed round. Additionally, their involvement in Concr, a techbio company enhancing ML-enabled biomarker discovery in oncology, showcases their commitment to integrating AI technologies in healthcare. These transactions highlight Debiopharm's strategic focus on leveraging AI to advance healthcare solutions.


13. Earlybird Venture Capital


Earlybird Venture Capital is a venture capital firm founded in 1997, based in Germany, that specializes in investing in European technology innovators. With a focus on digital health and deep tech sectors, Earlybird provides financial resources and strategic support to startups, helping them navigate growth challenges. Notably, they have participated in significant funding rounds for companies like Noscendo, which focuses on diagnostics, and Prothea Technologies, indicating their engagement in the healthcare technology space. Their investment strategy emphasizes nurturing early-stage companies, making them a valuable player in the evolving landscape of AI for healthcare.



AI for Healthcare Insights: Key Investors in DACH


InvestorHeadquarterSizeFoundedDeals 2024
NovartisBasel, Basel, Switzerland10001+19967
Novartis Venture FundBasel, Basel, Switzerland11-50199610
Verve VenturesZurich, Zurich, Switzerland11-50201025
SicticZurich, Zurich, Switzerland201-500201477
HBM Healthcare Investments AGZug, Zug, Switzerland1001-500020018
SpeedinvestVienna, Vienna, Austria51-200201145
Bayern KapitalLandshut, Bavaria, Germany11-50199527
Calm/StormVienna, Vienna, Austria1-10202013
b2ventureSt. Gallen, St. Gallen, Switzerland11-50200015
Wellington PartnersMunich, Bavaria, Germany11-5019989
IBB VenturesBerlin, Berlin, Germany11-50199718
DebiopharmLausanne, Vaud, Switzerland201-50019794
Earlybird Venture CapitalGermany51-200199729


Want to find more investors focusing on the ai for healthcare industry?

If you want to find more investors that are active in the ai for healthcareindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and there are a lot more private equity, venturecapital, and corporate investors like these globally.

With Inven, you'll also get to know:

  • Deal History: Number of deals and their sizes.
  • Portfolio: Companies they've invested in.
  • Contact data: Key dealmakers, including their emails and phonenumbers.
  • ...and much more!